These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22695964)

  • 1. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease.
    Huang JF; Zhang Y; Rittenhouse KD; Pickering EH; McDowell MT
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4556-64. PubMed ID: 22695964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
    Versura P; Profazio V; Campos EC
    Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
    Na KS; Mok JW; Kim JY; Rho CR; Joo CK
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests.
    VanDerMeid KR; Su SP; Ward KW; Zhang JZ
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1512-8. PubMed ID: 22323462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear osmolarity as a biomarker for dry eye disease severity.
    Suzuki M; Massingale ML; Ye F; Godbold J; Elfassy T; Vallabhajosyula M; Asbell PA
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4557-61. PubMed ID: 20393114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Dry Eye Workshop Dry Eye Severity Grading System With Tear Meniscus Measurement by Optical Coherence Tomography and Tear Osmolarity.
    Tukenmez-Dikmen N; Yildiz EH; Imamoglu S; Turan-Vural E; Sevim MS
    Eye Contact Lens; 2016 May; 42(3):153-7. PubMed ID: 26067398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
    Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis.
    Schargus M; Wolf F; Tony HP; Meyer-Ter-Vehn T; Geerling G
    Cornea; 2014 Dec; 33(12):1257-61. PubMed ID: 25255140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
    Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introducing a new parameter for the assessment of the tear film lipid layer.
    Ring MH; Rabensteiner DF; Horwath-Winter J; Boldin I; Hörantner R; Haslwanter T
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6638-44. PubMed ID: 22918634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
    Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
    Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual performance and the ocular surface in traumatic brain injury.
    Cockerham GC; Lemke S; Glynn-Milley C; Zumhagen L; Cockerham KP
    Ocul Surf; 2013 Jan; 11(1):25-34. PubMed ID: 23321357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness.
    Situ P; Simpson TL; Fonn D; Jones LW
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2971-6. PubMed ID: 18390645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease.
    Downie LE
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7260-8. PubMed ID: 26544794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.